Borreliosis diagnostics is often based on the clinical appearance together with anamnesis and the evidence of specific antibodies.
Fundamentally, a positiveBorrelia antibody test is separately no indicator for a therapy or reflects the clinical manifestations. In this case, detection ofBorrelia-specific effector T-cells can provide further diagnostic assistance.
The AID LymeSpot Kit detects and measures the Interferon-y expression ofBorrelia-specific effector T-cells
